Oriola-KD

Espoo, Finland Founded: 2006 • Age: 20 yrs
Offers comprehensive medicine distribution services to the biopharma sector.

About Oriola-KD

Oriola-KD was a Healthcare company based in Espoo (Finland) founded in 2006. It offers comprehensive medicine distribution services to the biopharma sector. It operates on a B2B model. Oriola-KD has completed 1 acquisition, including MedStop. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Distribution and Biopharma Services. Its competitors include McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology and 4 more; 4 of its 9 listed competitors have raised funding.

Company details

Oriola-KD operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, distribution, and biopharma services. Offers comprehensive medicine distribution services to the biopharma sector. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

  • Headquarters Espoo, Finland
  • Sectors
    Healthcare
  • Website oriola-kd.com
Key Metrics

Investments & Acquisitions by Oriola-KD

Oriola-KD has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MedStop.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Chain of drug stores
medstop.seStockholm, Sweden2007Jun 2013$225.82M
Premium access

Complete acquisition details for Oriola-KD

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Oriola-KD

2 dated milestones of Oriola-KD across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Oriola-KD is founded.
  2. Acquisition Acquires MedStop.

Competitors of Oriola-KD

Oriola-KD has 9 listed competitors in our database, 4 of them funded. They include McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
mckesson.com1833Irving, United States–51,000
Products and services are provided in the healthcare industry.
resilience.com1995San Diego, United States$1.99B–
Supply chain services for biopharma sector are provided.
enterohealthcare.com2018Mumbai, India$59.67M817
India's leading healthcare products distribution platform
bioascent.com2013Motherwell, United Kingdom$3.7M41
Compound management solutions are offered for drug discovery processes.
mingdutech.com2017Hangzhou, China$73.06M–
AI-based logistics services are provided in Hangzhou, China.
viveo.com.br1996Sao Paulo, Brazil––
Provider of logistic and supply chain services for biopharma sector
aspisotopes.com2021Boca Raton, United States–4
Supply chain solution services for isotope production are provided.
parexcellence.com1997Cincinnati, United States––
Supply chain logistics services are provided for the biopharma sector.
wipak.com2010Helsinki, Finland––
Provider of packaging and logistic services
Premium access

Detailed competitors of Oriola-KD

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Oriola-KD

The website of Oriola-KD (oriola-kd.com) receives about 1.2K visits a month.

  • Monthly visits
    1.2K

    ▼ 81.1% vs previous month

Similar websites

Websites whose visitors overlap most with Oriola-KD. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
oriola.com
100%
10.4K#1,931,488View details

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Oriola-KD (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Oriola-KD

Oriola-KD was founded in 2006.

Oriola-KD is headquartered in Espoo, Finland.

Oriola-KD operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, distribution, and biopharma services. Offers comprehensive medicine distribution services to the biopharma sector. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Oriola-KD's top competitors include Entero Healthcare, McKesson and Resilience.

Oriola-KD has made 1 acquisition, including MedStop.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available